Alemtuzumab CARE-MS I 5-year follow-upNeurol 89:1107-1116, Havrdova, E.,et al, 2017
Alemtuzumab CARE-MS II 5-year follow-upNeurol 89:1117-1126, Coles, A.J.,et al, 2017